URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679496/
Journal: Current Opinions in Clinical Nutrition and Metabolic Care
Publication Date: 07/2012
Summary: Obesity-associated nonalcoholic fatty liver disease (NAFLD) is highly prevalent, for which weight loss is the generally recommended clinical management. Low-carbohydrate ketogenic diets have been successful in promoting weight loss, but variations in the range of metabolic responses to these diets indicate that the effects of altering macronutrient content are not completely understood. This review focuses on the most recent findings that reveal the relationship between low-carbohydrate diets and NAFLD in rodent models and humans. Low-carbohydrate diets have been shown to promote weight loss, decrease intrahepatic triglyceride content, and improve metabolic parameters of patients with obesity. These ketogenic diets also provoke weight loss in rodents. However, long-term maintenance on a ketogenic diet stimulates the development of NAFLD and systemic glucose intolerance in mice. The relationship between ketogenic diets and systemic insulin resistance in both humans and rodents remains to be elucidated. Because low-carbohydrate ketogenic diets are increasingly employed for treatment of obesity, NAFLD, and neurological diseases such as epilepsy, understanding the long-term systemic effects of low-carbohydrate diets is crucial to the development of efficacious and safe dietary interventions.
Key Takeaways
Low Carbohydrate Ketogenic Diets are shown to be highly effective for weight loss and reduction of fatty liver. However, long term ketogenic diets in mice induced fatty liver. This study calls for further research in long term low carbohydrate diets to assess unintended health consequences. We must ask the question: Are outcomes in mice going to be the same in humans? Likely not as we are different species, which is why this study calls for more long term data in humans to assess safety.
